Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA-122 (miR-122) is a highly conserved, liver-specific microRNA that plays critical roles in hepatic biology, disease, and metabolism. It is one of the most abundant miRNAs in the liver, constituting up to 70% of total hepatic miRNAs. It functions primarily through binding to complementary sequences within the 3′ untranslated regions (UTRs) of target mRNAs via its seed sequence, leading to mRNA degradation or translational repression.
Binds to the 3' UTR of target mRNAs, leading to mRNA degradation or translational repression.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA-122 (miR-122).